Dr Scott Walker
- Email: email@example.com
- Address: Lab 2.017
Northern Institute for Cancer Research
Paul O'Gorman Building
Newcastle upon Tyne
My postdoctoral research focuses on investigating the functional significance of kinase inhibitors in prostate cancer progression. This has Included the evaluation of a panel of pre--‐clinical antagonists, assessing compound potency in an array of molecular and phenotypic cellular assays.
Invited Seasonal Lecturer in Pharmacology, delivering hour-long lectures to a body of four
hundred first year students at the University of Newcastle.
Pharmacology and Cell Biology Seminar Leader, delivering hour-long seminars to small
groups of 30 students at the University of Newcastle.
PhD, Masters and Undergraduate Supervisor providing supervision, training and pastoral care
for students at the University of Newcastle
- McClurg UL, Harle VJ, Nabbi A, Batalha-Pereira A, Walker S, Coffey K, Gaughan L, McCracken SRC, Robson CN. Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer. Oncotarget 2015, 6(35).